As of Aug 28
| +0.15 / +2.68%|
The 2 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 11.50, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +100.35% increase from the last price of 5.74.
The current consensus among 2 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.